Herbesan Ginkgo biloba bio
Food supplement declared in France, declaration No 2017-1-112
Herbesan Ginkgo biloba bio, from LABORATOIRES SUPER DIET, is a food supplement declared in France. Status: withdrawal from the market announced for 19 June 2029. Main ingredients: Ginkgo biloba 1,200 mg per day. 1 rule of use applies to its ingredients (limits and warnings).
- Brand
- Herbesan
- Food business operator placing the product on the market
- LABORATOIRES SUPER DIET
- Status
- Withdrawal from the market announced for 19 June 2029
- Form
- Ampoule
- Daily dose
- 1 ampoule
- Directions for use
- pure ou diluée dans un demi-verre d'eau, le matin
- Not recommended (according to the manufacturer)
- Breastfeeding women, Pregnant women, Taking antidepressants
- Objectives stated by the manufacturer (these are not authorised claims)
- Memory, Blood and lymphatic circulation
Declaration 276573, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Ginkgo biloba L. | Feuille | Extrait fluide aqueux | 1,200 mg |
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Label warnings
Dans autres de Consommation déconseillée (non visible) : ne convient pas en cas d'hypersensibilité au ginkgo. Consultez votre médecin en cas de prise simultanée d’anticoagulants ou d’anti-agrégants plaquettaires, ou en cas de troubles de la coagulation. Il n'est pas recommandé de prendre ce complément alimentaire dans les sept jours précédant une opération chirurgicale.
Regulatory points
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
- Information
Withdrawal from the market announced for 19 June 2029, according to Compl'Alim.
Source: Compl'Alim, food supplement declarations (France).
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Ginkgo biloba L.
Read the warning, when it applies and the studies cited
GINKGO - GINKGO BILOBA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).
Sources cited by Health Canada (3)
- Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
- WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
- OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).
Sources cited by Health Canada (1)
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
Contraindications
Do not use if you are having a surgery (Gardner and McGuffin 2013).
Sources cited by Health Canada (1)
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).
Sources cited by Health Canada (3)
- Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
- Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
- Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : Herbesan
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Herbesan Ginkgo biloba bio: composition and regulation”, https://compoatlas.com/en/supplements/products/276573-herbesan-ginkgo-biloba-bio, updated 15 November 2026.